Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial

Abstract Background The treatment of acute promyelocytic leukemia (APL) has been revolutionized in the past two decades by the advent of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). It suggests that non-high-risk APL patients can be cured without chemotherapy. However, ATRA plus chemot...

詳細記述

書誌詳細

主要な著者:	Xinxin Zhang, Huiyun Zhang, Limei Chen, Mengchang Wang, Jieying Xi, Xin Liu, Ming Xie, Dengzhe Li, Ekamjyot Singh Gulati, Sha Gong, Huaiyu Wang
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2018-09-01
シリーズ:	Trials
主題:	Acute promyelocytic leukemia Arsenic trioxide All-trans retinoic acid Hydroxyurea Mannitol
オンライン･アクセス:	http://link.springer.com/article/10.1186/s13063-018-2812-3
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!